Olanzapine Tablet, Orally Disintegrating
Product Images NDC 0527-3161

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 0527-3161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label (Olanzapine orally disintegrating tablets 10 mg, 30 tablets)

FDA Label Image

Package Label (Olanzapine orally disintegrating tablets 15 mg, 30 tablets)

FDA Label Image

Package Label (Olanzapine orally disintegrating tablets 20 mg, 30 tablets)

This is a description for a medication that needs to be stored at a temperature between 20°C to 25°C (68°F to 77°F). The medication is distributed by Lannett Company, Inc. based in Philadelphia, PA. It is manufactured by Sunshine Lake Pharma Co., Ltd. in Guangdong Province, China. The medication comes in a bottle containing 30 tablets. It is an orally dissolving tablet of Quetiapine and contains phenylalanine. For dosage information, refer to the accompanying USP literature.*

FDA Label Image

Package Label Front Panel (Olanzapine orally disintegrating tablets 5 mg, 30 tablets)

FDA Label Image

Logo (Logo1)

FDA Label Image

Logo (Logo2)

FDA Label Image

Chemical Structure (Olanzapine Chemical Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.